lenalid 5mg (Lenalidomide)
Lenalidomide 5 mg is an immunomodulatory medication used primarily in the treatment of certain blood cancers and hematological disorders.
Description
Lenalidomide 5 mg
Lenalidomide 5 mg is an immunomodulatory medication used primarily in the treatment of certain blood cancers and hematological disorders. It belongs to a class of drugs known as immunomodulatory agents and works by affecting the immune system, inhibiting the growth of abnormal cells, and reducing the formation of blood vessels that support tumor growth.
Indications
Lenalidomide 5 mg may be prescribed for:
- Multiple myeloma
- Myelodysplastic syndromes (MDS) associated with deletion 5q abnormality
- Mantle cell lymphoma
- Follicular lymphoma
- Other conditions as determined by a healthcare professional
Mechanism of Action
Lenalidomide exerts multiple therapeutic effects by:
- Modulating immune system activity
- Enhancing the function of T cells and natural killer (NK) cells
- Inhibiting the proliferation of malignant cells
- Reducing angiogenesis (formation of new blood vessels that support tumor growth)
Dosage and Administration
The dosage of Lenalidomide varies depending on the disease being treated, patient characteristics, and kidney function. Lenalidomide 5 mg capsules should be taken exactly as prescribed by a healthcare provider, with or without food, and swallowed whole with water.
Common Side Effects
Some commonly reported side effects include:
- Fatigue
- Anemia
- Neutropenia (low white blood cell count)
- Thrombocytopenia (low platelet count)
- Diarrhea or constipation
- Rash
- Muscle cramps
Warnings and Precautions
- Lenalidomide can cause severe birth defects if taken during pregnancy.
- Regular blood tests are required to monitor blood cell counts.
- Patients may have an increased risk of blood clots and infections.
- Dose adjustments may be necessary in patients with kidney impairment.
Storage
Store Lenalidomide 5 mg capsules at room temperature, protected from moisture and direct sunlight. Keep out of reach of children.
Conclusion
Lenalidomide 5 mg is an important therapeutic option for the management of several hematological malignancies and disorders. Due to its potential risks and side effects, treatment should be closely supervised by a qualified healthcare professional.








Reviews
There are no reviews yet.